USA IPO calendar: how U.S. IPOs work and what the table shows
A dated table of U.S. offerings compiled from exchange and SEC pages, with a plain explanation of how an IPO moves from filing to first trade and what to understand before reading one.
Prepared by Prem Tax and Accounting Corp. Last checked against official sources on October 23, 2026.
The USA IPO calendar below lists initial public offerings that have recently priced, are expected to price soon, or have only been filed with the SEC. It is a dated snapshot compiled from exchange and SEC pages. For anything you plan to rely on, the official calendars linked lower down are the place to confirm it.
The table shows its own “as of” date. Statuses such as filed, expected to price and priced describe where each offering stood on that date. They change, and offerings are sometimes delayed or withdrawn.
Table as of October 23, 2026. 15 offerings are listed. Dates are those shown by the exchange or the filing, and they can change or be withdrawn without notice.
| Company | Exchange | Ticker | Expected date | Price range | Size | Status | Source |
|---|---|---|---|---|---|---|---|
| Retension Pharmaceuticals, Inc. | NASDAQ | RTSN | Oct 9, 2026 | $12.00 | $45,000,000 (3,750,000 shares) | Priced | Filing |
| TRex Bio, Inc. | NASDAQ | TRXB | Oct 9, 2026 | $14.00 | $116,666,676 (8,333,334 shares) | Priced | Filing |
| Frazier Life Sciences Acquisition Corp. II | NASDAQ | FLSC | Oct 14, 2026 | $10.00 | $75,000,000 (7,500,000 shares) | Priced | Filing |
| Amaero Inc. | NASDAQ | AMRO | Oct 15, 2026 | $4.25 | $20,000,003 (4,705,883 shares) | Priced | Filing |
| Iambic Therapeutics, Inc. | NASDAQ | IAM | Oct 15, 2026 | $16.00 | $150,000,000 (9,375,000 shares) | Priced | Filing |
| City Therapeutics, Inc. | NASDAQ | CTY | Oct 16, 2026 | $18.00 | $199,999,998 (11,111,111 shares) | Priced | Filing |
| TCGX Acquisition Corp. II | NASDAQ | TCXB | Oct 16, 2026 | $10.00 | $100,000,000 (10,000,000 shares) | Priced | Filing |
| Lycia Therapeutics, Inc. | NASDAQ | LYCA | Oct 23, 2026 | $16.00-$18.00 | 14,700,000 shares (Nasdaq calendar offer amount $304,290,000) | Expected to price | Filing |
| DayOne Data Centers Ltd | NASDAQ | DODC | TBD | - | - | Filed | Filing |
| Centinel Spine Holdco, Inc. | NYSE | CNTL | TBD | - | - | Filed | Filing |
| Bambusa Therapeutics, Inc. | NASDAQ | BBTX | TBD | - | - | Filed | Filing |
| Patriot Mobile Inc. | NASDAQ | PTRT | TBD | - | - | Filed | Filing |
| Simwon America Corp. | NASDAQ | SWA | TBD | $18.00-$22.00 | 2,500,000 shares; $45-55 million excluding over-allotment | Filed | Filing |
| Aspen Neuroscience, Inc. | NASDAQ | ASPE | TBD | - | - | Filed | Filing |
| Sensing4D AI Ltd | NASDAQ | - | TBD | - | - | Filed | Filing |
How this table was compiled
Read Nasdaq's IPO calendar feed (api.nasdaq.com, October 2026; November 2026 returned no records) and confirmed each priced deal against its SEC 424B4 and Lycia's terms against its 2026-10-20 S-1/A; dates are as shown on the Nasdaq calendar (prospectuses are dated a day earlier), and filed-only items are preliminary prospectuses with blank terms unless a range is shown, listed by original filing date. The NYSE IPO center page loads its tables with JavaScript and showed no rows, so NYSE-only deals could not be checked (Centinel Spine is NYSE per its S-1); follow-on offerings and resale registrations found on EDGAR were excluded.
- Nasdaq IPO calendar data feed, October 2026 (behind nasdaq.com/market-activity/ipos)
- Nasdaq IPO calendar data feed, November 2026 (no records)
- SEC EDGAR full-text search, Form 424B4 filings 2026-10-06 to 2026-10-23
- SEC EDGAR full-text search, Lycia Therapeutics S-1/A
How an IPO works in the U.S.
The company registers the offering
The SEC explains that a company may not lawfully offer or sell shares unless the offering is registered with the SEC or an exemption applies. To register, it files a registration statement, typically on Form S-1. A central part is the prospectus, the document describing the company and the terms of the IPO.
SEC staff reviews the disclosure
The staff checks registration statements for compliance with disclosure rules, and its review often leads to changes to the prospectus. It does not evaluate the merits of the IPO. Staff comment letters are posted on EDGAR at least 20 business days after the registration statement is declared effective.
Underwriters gather demand and recommend a price
Underwriters are the investment banks that manage and sell the IPO. They collect indications of interest, the “order book”, and use them to recommend a price. The company, as issuer, ultimately decides the price.
The registration is declared effective, shares are priced and listed
Once comments are addressed, the staff issues an order declaring the registration effective, and the company can proceed. The company usually applies to list on an exchange such as the New York Stock Exchange or Nasdaq. A final prospectus, usually filed as a 424B3 or 424B4, shows the final price.
Trading starts and the lock-up clock runs
Insiders typically agree not to sell for a set period, most commonly 180 days. After listing, the company must publish quarterly and annual financial statements on Forms 10-Q and 10-K.
How to use an IPO calendar
- Read the status first. Filed means a registration statement is on file, possibly with terms still blank. Expected to price means a date was scheduled. Priced means a final price was set.
- Open the filing. The table links to the SEC filing for each entry. The prospectus is where the business, the risks and the use of the money are laid out. The SEC suggests reading its sections on risk factors, use of proceeds, dividend policy and dilution.
- Compare the price range with the final price. A range is a first estimate. The SEC says the final price is a negotiated estimate and may bear little relationship to the price at which the shares trade afterwards.
- Remember that the table is not complete. It shows what the compilers could confirm on official pages on the date given. The official calendars below are the reference.
Risks to understand
The SEC states that, by their nature, IPOs can be risky and speculative investments. The closing price shortly after an IPO is often well above or well below the offering price. Underwriters may support the price during the first days of trading, and once that support ends the price can fall far below the offering price. When a lock-up ends, a large number of shares can become available to sell. And because underwriters and the company control allocation, the SEC notes that individuals may have difficulty getting shares in a popular IPO at all.
Where the official calendars and filings are
- Nasdaq IPO calendar and NYSE IPO Center for scheduled and recent exchange listings.
- SEC EDGAR search for registration statements (Form S-1), final prospectuses (424B filings) and company reports. The SEC's guide to using EDGAR explains how to read them.
- The SEC's investor bulletin on investing in an IPO and its page on lockup agreements.
Tax notes
Shares you buy in an IPO are taxed like any other stock: your holding period starts when you acquire them, a sale after more than one year is long-term and a sale within a year or less is short-term. If you receive stock or options from an employer that goes public, the timing of tax is a topic of its own, and our start-up tax guide covers elections and deadlines that matter before a company is public. Investors outside the U.S. should read USA most active stocks and ETFs for withholding and estate-tax points, and families with accounts abroad should see foreign accounts and FBAR.
Common questions
Can an ordinary investor buy shares at the IPO price?
Sometimes. The SEC says that if you are a client of an underwriter in the IPO, you may be offered shares at the offering price, but underwriters and dealers often place most shares with institutions and high net-worth clients. The more common route for individuals is to buy after trading begins, at whatever the market price is then.
What is a lock-up?
It is an agreement that stops company insiders, such as employees, their friends and family and large shareholders, from selling for a set period after the IPO. Most lock-ups run 180 days, and the terms are disclosed in the prospectus. The SEC notes that a stock price may drop in anticipation of locked-up shares reaching the market.
Does SEC review mean an IPO is a good investment?
No. The staff reviews disclosure, and the SEC says that its declaration of effectiveness does not approve the merits of the IPO or indicate that the information is complete or accurate. Responsibility for accurate disclosure lies with the company and the others who prepared it.
What does “expected to price” mean in the table?
It means the offering was scheduled to set its final price on or around the date shown at the time of the table. Dates slip, and offerings are sometimes postponed or withdrawn, so check the exchange page and the latest prospectus before you rely on one.
Official sources
- Investor.gov: Updated investor bulletin, investing in an IPO (October 14, 2022)
- Investor.gov: Initial public offerings, lockup agreements
- Investor.gov: Why individuals have difficulty getting shares in an IPO
- Nasdaq: IPO calendar
- NYSE: IPO Center
- Investor.gov: Using EDGAR to research investments
Let's talk about your taxes, your business, your plans.
Tell us what you need and we will get back to you quickly. There is no pressure: just a friendly conversation and a clear next step.
4260 Westbrook Dr, Suite 107
Aurora, IL 60504